{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:47:37Z","timestamp":1793123257492,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,24]]},"DOI":"10.7759\/cureus.77936","type":"journal-article","created":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T01:38:16Z","timestamp":1737769096000},"source":"Crossref","is-referenced-by-count":3,"title":["Effects of Dose Reduction or Discontinuation of Benzodiazepine Hypnotics on Sleep and Anxiety in Patients With Insomnia After Long-Term Use"],"prefix":"10.7759","author":[{"given":"Hiroki","family":"Endo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Shigetsura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Tsurumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Sugita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsaku","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Terada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.6470","article-title":"Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline","volume":"13","author":"Sateia MJ","year":"2017","unstructured":"Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017, 13:307-49. 10.5664\/jcsm.6470","journal-title":"J Clin Sleep Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.9740\/mhc.2023.10.244","article-title":"Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports","volume":"13","author":"Del Rio Verduzco A","year":"2023","unstructured":"Del Rio Verduzco A, Salari A, Haghparast P. Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports. Ment Health Clin. 2023, 13:244-54. 10.9740\/mhc.2023.10.244","journal-title":"Ment Health Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2018.1491966","article-title":"Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review","volume":"19","author":"Strawn JR","year":"2018","unstructured":"Strawn JR, Geracioti L, Rajdev N, Clemenza K, Levine A. Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review. Expert Opin Pharmacother. 2018, 19:1057-70. 10.1080\/14656566.2018.1491966","journal-title":"Expert Opin Pharmacother"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2018.03.006","article-title":"The benzodiazepine binding sites of GABA(A) receptors","volume":"39","author":"Sigel E","year":"2018","unstructured":"Sigel E, Ernst M. The benzodiazepine binding sites of GABA(A) receptors. Trends Pharmacol Sci. 2018, 39:659-71. 10.1016\/j.tips.2018.03.006","journal-title":"Trends Pharmacol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1611832","article-title":"Treatment of benzodiazepine dependence","volume":"376","author":"Soyka M","year":"2017","unstructured":"Soyka M. Treatment of benzodiazepine dependence. N Engl J Med. 2017, 376:1147-57. 10.1056\/NEJMra1611832","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200418010-00004","article-title":"Cognitive effects of long-term benzodiazepine use: a meta-analysis","volume":"18","author":"Barker MJ","year":"2004","unstructured":"Barker MJ, Greenwood KM, Jackson M, Crowe SF. Cognitive effects of long-term benzodiazepine use: a meta-analysis. CNS Drugs. 2004, 18:37-48. 10.2165\/00023210-200418010-00004","journal-title":"CNS Drugs"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1988.tb06408.x","article-title":"Why low-dose benzodiazepine-dependent insomniacs can't escape their sleeping pills","volume":"78","author":"Schneider-Helmert D","year":"1988","unstructured":"Schneider-Helmert D. Why low-dose benzodiazepine-dependent insomniacs can't escape their sleeping pills. Acta Psychiatr Scand. 1988, 78:706-11. 10.1111\/j.1600-0447.1988.tb06408.x","journal-title":"Acta Psychiatr Scand"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/416864","article-title":"Mechanisms underlying tolerance after long-term benzodiazepine use: a future for subtype-selective GABA(A) receptor modulators?","volume":"2012","author":"Vinkers CH","year":"2012","unstructured":"Vinkers CH, Olivier B. Mechanisms underlying tolerance after long-term benzodiazepine use: a future for subtype-selective GABA(A) receptor modulators?. Adv Pharmacol Sci. 2012, 2012:416864. 10.1155\/2012\/416864","journal-title":"Adv Pharmacol Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1983.03340060045024","article-title":"Long-term diazepam therapy and clinical outcome","volume":"250","author":"Rickels K","year":"1983","unstructured":"Rickels K, Case WG, Downing RW, Winokur A. Long-term diazepam therapy and clinical outcome. JAMA. 1983, 250:767-71. 10.1001\/jama.1983.03340060045024","journal-title":"JAMA"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/gps.4310","article-title":"Quantification of adverse effects of regular use of triazolam on clinical outcomes for older people with insomnia: a retrospective cohort study","volume":"31","author":"Maeda T","year":"2016","unstructured":"Maeda T, Babazono A, Nishi T, Yasui M. Quantification of adverse effects of regular use of triazolam on clinical outcomes for older people with insomnia: a retrospective cohort study. Int J Geriatr Psychiatry. 2016, 31:186-94. 10.1002\/gps.4310","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref11","unstructured":"International Narcotics Control Board, United Nations. Psychotropic Substances 2016 - Technical Reports (E\/INCB\/2016\/3). (2016). Accessed. 25 January 2025: https:\/\/www.incb.org\/documents\/Psychotropics\/technical-publications\/2016\/Technical_Publication_2016_English.pdf."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-023-04683-2","article-title":"Hypnotic prescription trends and patterns for the treatment of insomnia in Japan: analysis of a nationwide Japanese claims database","volume":"23","author":"Okuda S","year":"2023","unstructured":"Okuda S, Qureshi ZP, Yanagida Y, Ito C, Homma Y, Tokita S. Hypnotic prescription trends and patterns for the treatment of insomnia in Japan: analysis of a nationwide Japanese claims database. BMC Psychiatry. 2023, 23:278. 10.1186\/s12888-023-04683-2","journal-title":"BMC Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-029641","article-title":"Factors associated with long-term prescription of benzodiazepine: a retrospective cohort study using a health insurance database in Japan","volume":"9","author":"Takano A","year":"2019","unstructured":"Takano A, Ono S, Yamana H, Matsui H, Matsumoto T, Yasunaga H, Kawakami N. Factors associated with long-term prescription of benzodiazepine: a retrospective cohort study using a health insurance database in Japan. BMJ Open. 2019, 9:e029641. 10.1136\/bmjopen-2019-029641","journal-title":"BMJ Open"},{"key":"ref14","unstructured":"The health care fee system, the Japanese Ministry of Health, Labour and Welfare (FY2012 medical fee revision). (2012). Accessed. 25 January 2025: https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/kenkou_iryou\/iryouhoken\/iryouhoken15\/."},{"key":"ref15","unstructured":"The health care fee system, the Japanese Ministry of Health, Labour and Welfare (FY2018 Medical Fee Revision). (2018). Accessed. 25 January 2025: https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/0000188411.html."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.12275","article-title":"Psychotropic dose equivalence in Japan","volume":"69","author":"Inada T","year":"2015","unstructured":"Inada T, Inagaki A. Psychotropic dose equivalence in Japan. Psychiatry Clin Neurosci. 2015, 69:440-7. 10.1111\/pcn.12275","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s1389-9457(00)00065-4","article-title":"Validation of the Insomnia Severity Index as an outcome measure for insomnia research","volume":"2","author":"Bastien CH","year":"2001","unstructured":"Bastien CH, Valli\u00e8res A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001, 2:297-307. 10.1016\/s1389-9457(00)00065-4","journal-title":"Sleep Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse DJ","year":"1989","unstructured":"Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989, 28:193-213. 10.1016\/0165-1781(89)90047-4","journal-title":"Psychiatry Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-1781(00)00232-8","article-title":"Psychometric assessment of subjective sleep quality using the Japanese version of the Pittsburgh Sleep Quality Index (PSQI-J) in psychiatric disordered and control subjects","volume":"97","author":"Doi Y","year":"2000","unstructured":"Doi Y, Minowa M, Uchiyama M, Okawa M, Kim K, Shibui K, Kamei Y. Psychometric assessment of subjective sleep quality using the Japanese version of the Pittsburgh Sleep Quality Index (PSQI-J) in psychiatric disordered and control subjects. Psychiatry Res. 2000, 97:165-72. 10.1016\/s0165-1781(00)00232-8","journal-title":"Psychiatry Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer RL","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JB, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006, 166:1092-7. 10.1001\/archinte.166.10.1092","journal-title":"Arch Intern Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1159\/000524400","article-title":"Benzodiazepines remain important therapeutic options in psychiatric practice","volume":"91","author":"Dubovsky SL","year":"2022","unstructured":"Dubovsky SL, Marshall D. Benzodiazepines remain important therapeutic options in psychiatric practice. Psychother Psychosom. 2022, 91:307-34. 10.1159\/000524400","journal-title":"Psychother Psychosom"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.182.6.498","article-title":"Tapering off long-term benzodiazepine use with or without group cognitive-behavioural therapy: three-condition, randomised controlled trial","volume":"182","author":"Voshaar RC","year":"2003","unstructured":"Voshaar RC, Gorgels WJ, Mol AJ, et al.. Tapering off long-term benzodiazepine use with or without group cognitive-behavioural therapy: three-condition, randomised controlled trial. Br J Psychiatry. 2003, 182:498-504. 10.1192\/bjp.182.6.498","journal-title":"Br J Psychiatry"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-003-1759-5","article-title":"Sleep-promoting properties of quetiapine in healthy subjects","volume":"174","author":"Cohrs S","year":"2004","unstructured":"Cohrs S, Rodenbeck A, Guan Z, Pohlmann K, Jordan W, Meier A, R\u00fcther E. Sleep-promoting properties of quetiapine in healthy subjects. Psychopharmacology (Berl). 2004, 174:421-9. 10.1007\/s00213-003-1759-5","journal-title":"Psychopharmacology (Berl)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2003.06.006","article-title":"The effects of trazodone on sleep in patients treated with stimulant antidepressants","volume":"5","author":"Kaynak H","year":"2004","unstructured":"Kaynak H, Kaynak D, G\u00f6z\u00fckirmizi E, Guilleminault C. The effects of trazodone on sleep in patients treated with stimulant antidepressants. Sleep Med. 2004, 5:15-20. 10.1016\/j.sleep.2003.06.006","journal-title":"Sleep Med"},{"key":"ref25","article-title":"Trazodone for insomnia: a systematic review","volume":"14","author":"Jaffer KY","year":"2017","unstructured":"Jaffer KY, Chang T, Vanle B, et al.. Trazodone for insomnia: a systematic review. Innov Clin Neurosci. 2017, 14:24-34.","journal-title":"Innov Clin Neurosci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1177\/20451253221145561","article-title":"Enduring neurological sequelae of benzodiazepine use: an Internet survey","volume":"13","author":"Huff C","year":"2023","unstructured":"Huff C, Finlayson AJ, Foster DE, Martin PR. Enduring neurological sequelae of benzodiazepine use: an Internet survey. Ther Adv Psychopharmacol. 2023, 13:20451253221145561. 10.1177\/20451253221145561","journal-title":"Ther Adv Psychopharmacol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.10946","article-title":"A retrospective clinical practice study comparing the usefulness of dual-orexin receptor antagonists and a melatonin receptor agonist in patients switching from long-term benzodiazepine receptor agonists","volume":"20","author":"Tachibana M","year":"2024","unstructured":"Tachibana M, Kanahara N, Oda Y, Hasegawa T, Kimura A, Iyo M. A retrospective clinical practice study comparing the usefulness of dual-orexin receptor antagonists and a melatonin receptor agonist in patients switching from long-term benzodiazepine receptor agonists. J Clin Sleep Med. 2024, 20:603-13. 10.5664\/jcsm.10946","journal-title":"J Clin Sleep Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.10668","article-title":"Switching to lemborexant for the management of insomnia in mental disorders: the SLIM study","volume":"19","author":"Horikoshi S","year":"2023","unstructured":"Horikoshi S, Miura I, Suzuki Y, et al.. Switching to lemborexant for the management of insomnia in mental disorders: the SLIM study. J Clin Sleep Med. 2023, 19:1753-8. 10.5664\/jcsm.10668","journal-title":"J Clin Sleep Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.7326\/M15-1781","article-title":"Pharmacologic treatment of insomnia disorder: an evidence report for a clinical practice guideline by the American College of Physicians","volume":"165","author":"Wilt TJ","year":"2016","unstructured":"Wilt TJ, MacDonald R, Brasure M, et al.. Pharmacologic treatment of insomnia disorder: an evidence report for a clinical practice guideline by the American College of Physicians. Ann Intern Med. 2016, 165:103-12. 10.7326\/M15-1781","journal-title":"Ann Intern Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.7230","article-title":"Use of actigraphy for the evaluation of sleep disorders and circadian rhythm sleep-wake disorders: an American Academy of Sleep Medicine clinical practice guideline","volume":"14","author":"Smith MT","year":"2018","unstructured":"Smith MT, McCrae CS, Cheung J, Martin JL, Harrod CG, Heald JL, Carden KA. Use of actigraphy for the evaluation of sleep disorders and circadian rhythm sleep-wake disorders: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2018, 14:1231-7. 10.5664\/jcsm.7230","journal-title":"J Clin Sleep Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/320094-effects-of-dose-reduction-or-discontinuation-of-benzodiazepine-hypnotics-on-sleep-and-anxiety-in-patients-with-insomnia-after-long-term-use","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T01:38:21Z","timestamp":1737769101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/320094-effects-of-dose-reduction-or-discontinuation-of-benzodiazepine-hypnotics-on-sleep-and-anxiety-in-patients-with-insomnia-after-long-term-use"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.77936","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,24]]}}}